FFGENFibroGen Inc

FibroGen Inc

FGEN

1D · 1W · 1M · 3M · YTD · 1Y · 5Y · AllLive FGEN chart

  • Mkt cap

    $39.28M

  • EV/Sales

    -1.33

  • P/E ratio

    N/A

  • FY2025 Revenue

    $6.44M

  • EPS (TTM)

    $45.31

  • Gross Margin (FY2025)

    91.37%

  • Profit Margin (FY2025)

    2848.63%

  • Beta

    N/A

  • Div yield

    N/A

  • Sector

    Healthcare

No recent filings in cache.

Live FGEN terminalLician Pro · $19.99/mo or $149/yrPeer financials on ProAPI free 100/dayCompare AAPL vs MSFT

FGEN — FibroGen Inc · rev $6.4M

FGEN Key Statistics

  • Market Cap: $39.3M
  • P/B Ratio: 53.8

FibroGen Inc latest statements (FY2025)

Latest cached year on this hub. Full FGEN income, balance, and cash tables.

  • Revenue$6.4M
  • Net Income$183.5M
  • Total Assets$119.6M
  • Free Cash Flow-$4.8M

FGEN FAQ

What industry is FGEN in?

FibroGen Inc (FGEN) is a biotechnology company in the Healthcare sector.

What are FGEN's latest revenue and net income?

Latest cached FibroGen Inc (FGEN) revenue for Dec 31, 2025 was $6.4M. Net income was $183.5M. Statements: https://lician.com/financials/fgen

What is FGEN's market cap?

FibroGen Inc (FGEN) market capitalization is $39.3M on the latest cached snapshot.

Live FGEN terminal loads when you scroll near this section.